Identification of tamoxifen–DNA adducts in the endometrium of women treated with tamoxifen
Data up to Jan 2025
Total Citations Per Year
Abstract
References (29)
Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study
1998 • 5,487 citations
Tamoxifen for early breast cancer: an overview of the randomised trials
1998 • 4,082 citations
Tamoxifen in the Treatment of Breast Cancer
1998 • 1,295 citations
Endometrial Cancer in Tamoxifen-Treated Breast Cancer Patients: Findings From the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14 *
1994 • 1,259 citations
Tamoxifen Therapy for Breast Cancer and Endometrial Cancer Risk
1999 • 348 citations
The triphenylethylene drug tamoxifen is a strong liver carcinogen in the rat
1993 • 235 citations
Correlation of DNA adduct levels with tumor incidence: carcinogenic potency of DNA adducts
1999 • 133 citations
A comparative study of tamoxifen metabolism in female rat, mouse and human liver microsomes
1994 • 110 citations
A mechanistic hypothesis for DNA adduct formation by tamoxifen following hepatic oxidative metabolism
1994 • 104 citations
32P-Postlabelled DNA adducts in liver obtained from women treated with tamoxifen
1995 • 100 citations
The tamoxifen dilemma
1999 • 96 citations
Detection of DNA adducts in HL-60 cells treated with hydroquinone and p-benzoquinone by 32P-postlabeling
1991 • 93 citations
Sulfation of alpha-hydroxytamoxifen catalyzed by human hydroxysteroid sulfotransferase results in tamoxifen-DNA adducts
1998 • 80 citations
Tamoxifen−DNA Adducts Detected in the Endometrium of Women Treated with Tamoxifen
1999 • 80 citations
Identification of Tamoxifen−DNA Adducts Formed by α-Sulfate Tamoxifen and α-Acetoxytamoxifen
1997 • 79 citations
Reduced genotoxicity of [D5-ethyl]-tamoxifen implicates α-hydroxylation of the ethyl group as a major pathway of tamoxifen activation to a liver carcinogen
1994 • 77 citations
Identification of tamoxifen-DNA adducts formed by 4-hydroxytamoxifen quinone methide
1997 • 66 citations
The metabolic activation of tamoxifen and alpha-hydroxytamoxifen to DNA- binding species in rat hepatocytes proceeds via sulphation
1998 • 61 citations
Does tamoxifen cause cancer in humans?
1998 • 60 citations
Lack of evidence from HPLC 32P-post-labelling for tamoxifenDNA adducts in the human endometrium
1999 • 58 citations
The deuterium isotope effect for the α-hydroxylation of tamoxifen by rat liver microsomes accounts for the reduced genotoxicity of [D5-ethyl]tamoxifen
1995 • 53 citations
Comparison of the DNA adducts formed by tamoxifen and 4-hydroxytamoxifen in vivo
1999 • 50 citations
Aspects of metabolism of tamoxifen by rat liver microsomes
1986 • 43 citations
The mercenary business: ‘executive outcomes’
1997 • 41 citations
Evaluation of tamoxifen and alpha-hydroxytamoxifen 32P-post-labelled DNA adducts by the development of a novel automated on-line solid-phase extraction HPLC method
1998 • 38 citations
Minor products of reaction of DNA with alpha-acetoxytamoxifen
1997 • 33 citations
Miscoding Potential of Tamoxifen-Derived DNA Adducts: α-(N2-Deoxyguanosinyl)tamoxifen
1997 • 31 citations
Lifetime and Reactivity of an Ultimate Tamoxifen Carcinogen: The Tamoxifen Carbocation
1998 • 24 citations
Tamoxifen−DNA Adducts Formed by α-Acetoxytamoxifen N-Oxide
1999 • 17 citations